Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1999-6-14
pubmed:abstractText
Findings from previous multicenter clinical trials have suggested that tirilazad mesylate, a synthetic nonhormonal 21-aminosteroid, might be effective in preventing delayed cerebral ischemia following subarachnoid hemorrhage (SAH). This beneficial effect, however, was greater in males than females, possibly because of gender-related pharmacokinetic differences. The authors sought to assess the effects of administering a larger dose of tirilazad in women with SAH.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-3085
pubmed:author
pubmed:issnType
Print
pubmed:volume
90
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1011-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10350245-Dose-Response Relationship, Drug, pubmed-meshheading:10350245-Double-Blind Method, pubmed-meshheading:10350245-Female, pubmed-meshheading:10350245-Humans, pubmed-meshheading:10350245-Incidence, pubmed-meshheading:10350245-International Cooperation, pubmed-meshheading:10350245-Intracranial Aneurysm, pubmed-meshheading:10350245-Ischemic Attack, Transient, pubmed-meshheading:10350245-Middle Aged, pubmed-meshheading:10350245-Nervous System, pubmed-meshheading:10350245-Neuroprotective Agents, pubmed-meshheading:10350245-Pharmaceutical Vehicles, pubmed-meshheading:10350245-Pregnatrienes, pubmed-meshheading:10350245-Prospective Studies, pubmed-meshheading:10350245-Subarachnoid Hemorrhage, pubmed-meshheading:10350245-Time Factors, pubmed-meshheading:10350245-Treatment Outcome
pubmed:year
1999
pubmed:articleTitle
Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
pubmed:affiliation
Department of Neurological Surgery and Virginia Neurological Institute, University of Virginia, Charlottesville 22908, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study